Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Monday, November 23, 2009, 4:37AM ET - U.S. Markets open in 4 hours and 53 minutes. Dow Down 0.14% Nasdaq  0.00%
pSivida Corp. (PSDV)On Nov 20: 4.09   0.00 (0.00%)  
MORE ON PSDV
Quotes
Charts
News & Info
Company
HereProfile
Analyst Coverage
Ownership
Financials

ProfileGet Profile for:
pSivida Corp.
400 Pleasant Street
Watertown, MA 02472
United States - Map
Phone: 617-926-5000
Fax: 617-926-5050
Web Site: http://www.psivida.com

DETAILS 
Index Membership:N/A
Sector:Healthcare
Industry:Drug Delivery
Full Time Employees:22

BUSINESS SUMMARY 
pSivida Corp., together with its subsidiaries, develops drug delivery products in the healthcare sector. It develops products utilizing its proprietary technologies, including Durasert, BioSilicon, CODRUG, and Medidur. The company’s products include Retisert for the treatment of posterior uveitis; and Vitrasert for the treatment of AIDS-related cytomegalovirus retinitis. Its products also include Iluvien, a Phase III clinical trial product for the treatment of diabetic macular edema; and Durasert and Iluvien, which are under pre-clinical trials to treat retinitis pigmentosa and age-related macular degeneration. In addition, pSivida Corp. owns the rights to develop and commercialize a modified form of silicon, known as BioSilicon, which has therapeutic applications for treatment of cancer. Its lead BioSilicon product is BrachySil, which is in Phase II clinical trial for the treatment of pancreatic cancer. The company primarily operates in the United Kingdom and the United States. It has strategic collaborations with Chiron Vision Corporation; Bausch & Lomb Incorporated; Alimera Sciences, Inc.; Pfizer, Inc.; and Intrinsiq Materials Cayman Limited. The company was founded in 1987 and is based in Watertown, Massachusetts.
Key Statistics

COMPANY WEBSITES 
  • Home Page
  • Search Yahoo! for:
    More on pSivida Corp.


    KEY EXECUTIVES 
     PayExercised
    Dr. Paul Ashton B.Sc., Ph.D., 48
    Chief Exec. Officer, Pres, Exec. Director, Interim Pres of pSivida Inc of pSivida Inc
    $ 495.00K $ 0
    Mr. Leonard S. Ross , 59
    Principal Financial Officer, Principal Accounting Officer and Corp. Controller
    $ 197.00K $ 0
    Ms. Lori H. Freedman Esq., B.A., J.D., 43
    VP of Corp. Affairs, Sec., Gen. Counsel, VP of Corp. Affairs - pSivida Inc, Gen. Counsel of pSivida Inc, Sec. of pSivida Inc of pSivida Inc
    $ 371.00K $ 0
    Prof. Leigh T. Canham ,
    Chief Scientific Officer, Chief Scientific Officer of pSiMedica Limited, Director of pSiMedica Limited, Director of AION Diagnostics Limited and Director of pSiNutria Limited
    N/A N/A
    Dr. Anna Kluczewska B. D.Sc.,
    Managing Director of AION Diagnostics Limited of AION Diagnostics Limited
    N/A N/A
    Dollar amounts are as of 31-Dec-09 and compensation values are for the last fiscal year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of options exercised during the fiscal year.
    View Insiders


    Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
    Get Profile for Another Symbol: Symbol Lookup
    Annual ReportsSector Analysis